cGAS-STING signaling pathway in lung cancer: Regulation on antitumor immunity and application in immunotherapy

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• The innate immune system defends against pathogens and influences tumor progression.
• The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is a key innate immune signaling cascade.
• Emerging evidence highlights the cGAS-STING pathway's role in lung cancer development.

Purpose of the Study:

• To provide a comprehensive review of cGAS-STING pathway research in lung cancer.
• To elucidate the pathway's involvement in lung cancer pathogenesis.
• To assess the therapeutic potential of targeting the cGAS-STING pathway for lung cancer treatment.

Main Methods:

• Literature review of current research on the cGAS-STING pathway and lung cancer.
• Analysis of studies investigating the molecular mechanisms of cGAS-STING in tumor immunity.
• Synthesis of findings related to therapeutic strategies targeting the cGAS-STING pathway.

Main Results:

• The cGAS-STING pathway plays a dual role in cancer immunity, influencing both tumor suppression and promotion.
• Dysregulation of cGAS-STING signaling is implicated in lung cancer initiation and progression.
• Activation of cGAS-STING can lead to cytokine secretion, impacting the tumor microenvironment.

Conclusions:

• The cGAS-STING pathway represents a promising target for novel lung cancer therapies.
• Further research is needed to fully understand the pathway's complex role in lung cancer.
• Targeting cGAS-STING may offer new avenues for immunotherapeutic interventions in lung cancer.